United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 3, 2026 · Filed Aug 4, 2026

On Aug 3, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$516.06 for US$4.9M under a trading plan, leaving 324,443 shares. Filed Aug 4, 2026 (Form 4).

Sold
9,500 shares
Price
US$516.06 average (US$514.83 to US$518.61)
Value
US$4.9M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 3, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 3, 2026Common StockSale1,667US$514.83332,276Indirect
Aug 3, 2026Common StockSale4,218US$515.73328,058Indirect
Aug 3, 2026Common StockSale2,075US$516.49325,983Indirect
Aug 3, 2026Common StockSale1,220US$517.49324,763Indirect
Aug 3, 2026Common StockSale320US$518.61324,443Indirect

Source

View original at SEC

Related